Global multi‐specialty clinician perspectives on the implementation of Alzheimer's disease blood biomarkers
Surveyed clinicians generally agreed with published appropriate use recommendations but were divided on AD BBM readiness for clinical use.
Authors
- Ana Carolina Pereira
- Leyla Anderson
- Chinedu Udeh‐Momoh (ORCID: https://orcid.org/0000-0002-7357-4692)
- Erin E. Cawston (ORCID: https://orcid.org/0000-0003-2560-1630)
- Lindsey A. Kuchenbecker (ORCID: https://orcid.org/0000-0002-2987-1040)
- Alicia Algeciras‐Schimnich (ORCID: https://orcid.org/0000-0002-4455-6217)
- Ashvini Keshavan (ORCID: https://orcid.org/0000-0003-1043-5721)
- Melissa M. Budelier (ORCID: https://orcid.org/0000-0002-1779-5757)
- Mari L. DeMarco
- Michelle M. Mielke (ORCID: https://orcid.org/0000-0001-7177-1185)
- Joanne Rodda (ORCID: https://orcid.org/0000-0002-2837-9265)
- Claudia Duran‐Aniotz
- Wyllians Vendramini Borelli
- Tinatin Chabrashvili
- Raphael Machado Castilhos
Institutions
- Providence Health Care (CA)
- Universidade Federal do Rio Grande do Sul (BR)
- University of British Columbia (CA)
- University of Auckland (NZ)
- Medway School of Pharmacy (GB)
- SUNY Upstate Medical University (US)
- Adolfo Ibáñez University (CL)
- WinnMed (US)
- Hospital Moinhos de Vento (BR)
- Aga Khan University Nairobi (KE)
- Kent and Medway NHS and Social Care Partnership Trust (GB)
- Mayo Clinic in Arizona (US)
- UK Dementia Research Institute (GB)
- NVision Eye Centers (United States) (US)
- Applied Research Associates (United States) (US)
- Mayo Clinic in Florida (US)
- National Hospital for Neurology and Neurosurgery (GB)
- Kent and Medway Medical School
- University College London (GB)
- Wake Forest University (US)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70856_100267
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00